Centene Corp Reports Director Changes and Compensation Updates

Ticker: CNC · Form: 8-K · Filed: 2024-11-12T00:00:00.000Z

Sentiment: neutral

Topics: management-change, compensation

TL;DR

Centene's board is shuffling, exec pay is changing. Watch for strategic shifts.

AI Summary

Centene Corporation announced on November 8, 2024, changes related to its board of directors and executive compensation. Specifically, the filing details the departure of directors, election of new directors, and adjustments to compensatory arrangements for certain officers. The company is incorporated in Delaware and headquartered in St. Louis, Missouri.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future financial performance.

Risk Assessment

Risk Level: medium — Changes in board and executive compensation can indicate internal shifts that may impact future performance or strategy.

Key Numbers

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates the departure of directors and the election of new directors, though specific names are not detailed in this summary section.

What is the nature of the changes to compensatory arrangements?

The filing states there are changes to 'Compensatory Arrangements of Certain Officers,' but the specifics of these arrangements are not provided in this summary.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated November 8, 2024.

In which state is Centene Corporation incorporated?

Centene Corporation is incorporated in Delaware.

What is the address of Centene Corporation's principal executive offices?

The principal executive offices are located at 7700 Forsyth Boulevard, St. Louis, Missouri 63105.

From the Filing

0001071739-24-000206.txt : 20241112 0001071739-24-000206.hdr.sgml : 20241112 20241112161543 ACCESSION NUMBER: 0001071739-24-000206 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241108 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 241448400 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20241108.htm 8-K cnc-20241108 0001071739 false 0001071739 2024-11-08 2024-11-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On November 8, 2024, Kenneth J. Fasola, President of Centene Corporation (the "Company"), informed the Company that he intends to retire from the Company on July 1, 2025. Between now and the end of 2024, Mr. Fasola will transition his current duties and thereafter serve as Strategic Advisor, reporting to Sarah M. London, the Company's Chief Executive Officer, until his retirement from the Company. The Company extends its sincere gratitude and congratulations to Mr. Fasola on the success and impact of his 40-year career in healthcare. SIGNATURE Pursuant to the requirements of the Securiti

View on Read The Filing